Goldilocks Therapeutics, Inc.
Biotechnology company · Bedford, New York, United States
Goldilocks Therapeutics, Inc. is a biotechnology company headquartered in Bedford, New York, United States. Its earliest recorded incorporation is in 2018. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $305,844 in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $1.2 million sold in a notice filed in 2021.
Goldilocks Therapeutics at a glance
What does Goldilocks Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $305,844 in total (2021). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $1.2 million sold (2021).
Frequently asked questions about Goldilocks Therapeutics
Where is Goldilocks Therapeutics headquartered?
Goldilocks Therapeutics, Inc. is headquartered in Bedford, New York, United States.
What does Goldilocks Therapeutics do?
Goldilocks Therapeutics, Inc. is a biotechnology company.
When was Goldilocks Therapeutics founded?
The earliest incorporation on record for Goldilocks Therapeutics, Inc. is in 2018, according to public company registers.
Similar companies
- First Light Biosciences Inc.Bedford, Massachusetts, United States
- Nanoscope Technologies LLCBedford, Texas, United States
- Kaleido Biosciences, Inc.Bedford, Massachusetts, United States
- Vox Biomedical LLCBedford, Massachusetts, United States
- Retain Health, Inc.Bedford, Massachusetts, United States
- N2 Biomedical, LLCBedford, Massachusetts, United States
- Pramand LLCBedford, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences